61,059 patents · 14,450 papers · 11,710 patents and 1,403 papers in the last 3 years.
Top assignees
- LOreal SA (1,097 patents)
- Genentech Inc (527 patents)
- Symrise AG (407 patents)
Notable patents
- Pharmaceutical formulations of resveratrol and methods of use thereof (2002)
- Administration of resveratrol to prevent or treat restenosis following coronary intervention (2001)
- THE USE OF RESVERATROL TO REGULATE EXPRESSION OF APOLIPOPROTEIN A1 (2004)
Notable papers
Top assignees
| Assignee | Patents |
|---|---|
| LOreal SA | 1,097 |
| Genentech Inc | 527 |
| Symrise AG | 407 |
| Pfizer Inc | 355 |
| Kenvue Brands LLC | 348 |
| DSM IP Assets BV | 330 |
| BASF SE | 324 |
| Pfizer Corp SRL | 310 |
| Nestec SA | 281 |
| Nicoventures Trading Ltd | 280 |
Top authors
| Author | Affiliation | Papers |
|---|---|---|
| Dipak K. Das | University of Connecticut | 48 |
| A Bertelli | University of Milan | 27 |
| Beata Olas | University of Łódź | 28 |
| Dominique Delmas | Université de Bourgogne | 28 |
| John M. Pezzuto | University of Illinois Chicago | 26 |
| Jia Liu | Dalian Medical University | 22 |
| María P. Portillo | University of the Basque Country | 19 |
| Hong Li | Dalian Medical University | 17 |
| Norbert Latruffe | Université de Bourgogne | 17 |
| Chi‐Tang Ho | Rutgers, The State University of New Jersey | 16 |
Top patents
| Title | Year | Assignee | Citations |
|---|---|---|---|
| Pharmaceutical formulations of resveratrol and methods of use thereof | 2002 | Pharmascience Inc | 200 |
| Administration of resveratrol to prevent or treat restenosis following coronary intervention | 2001 | Pharmascience Inc | 182 |
| THE USE OF RESVERATROL TO REGULATE EXPRESSION OF APOLIPOPROTEIN A1 | 2004 | RESVERLOGIX, INC. | 117 |
| Administration of resveratrol to treat inflammatory respiratory disorders | 2005 | Ip2ipo Innovations Ltd | 107 |
| Compositions based on resveratrol | 2003 | CAUDALIE | 97 |
Top papers
| Title | Year | Citations | Topic |
|---|---|---|---|
| Dose translation from animal to human studies revisited | 2007 | 6297 | Sirtuins and Resveratrol in Medicine |
| Resveratrol improves health and survival of mice on a high-calorie diet | 2006 | 4236 | Genetics, Aging, and Longevity in Model Organisms |
| Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α | 2006 | 3978 | Sirtuins and Resveratrol in Medicine |
| Therapeutic potential of resveratrol: the in vivo evidence | 2006 | 3888 | Sirtuins and Resveratrol in Medicine |
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | 2003 | 3762 | Genetics, Aging, and Longevity in Model Organisms |
Patent classifications
| Code | Area | Patents |
|---|---|---|
A61K | Medicinal preparations | 37,916 |
A61P | Therapeutic activity (drug indications) | 27,768 |
A61Q | Cosmetics, personal care | 12,368 |
A23L | Foods and beverages (general) | 8,836 |
A23V | Foods, foodstuffs - indexing scheme | 6,272 |
C07D | Heterocyclic compounds | 5,667 |
C12N | Microorganisms, enzymes | 5,383 |
C07K | Peptides | 3,813 |
G01N | Investigating / analysing materials | 3,372 |
Y02A | Climate change adaptation | 3,248 |
Research topics
| Topic | Papers |
|---|---|
| Sirtuins and Resveratrol in Medicine | 120 |
| Phytochemicals and Antioxidant Activities | 7 |
| Curcumin's Biomedical Applications | 6 |
| Mitochondrial Function and Pathology | 5 |
| Autophagy in Disease and Therapy | 4 |
| Cancer, Hypoxia, and Metabolism | 4 |
| Genomics, phytochemicals, and oxidative stress | 4 |
| Heme Oxygenase-1 and Carbon Monoxide | 4 |
| Nutrition, Genetics, and Disease | 4 |
| Alzheimer's disease research and treatments | 3 |
Frequently asked questions
What is the molecular formula and structure of resveratrol?
Resveratrol has the molecular formula C14H12O3 with a molecular weight of 228.247. Its canonical chemical name is 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, and it is also known by several synonyms including Polygonin and Cuspidatin.
Which companies hold the most patents related to resveratrol?
The leading assignees for resveratrol patents are L'Oreal SA with 1,097 patents, Genentech Inc with 527 patents, and Symrise AG with 407 patents. Other significant patent holders include Pfizer Inc and Kenvue Brands LLC.
What are the primary research topics associated with resveratrol studies?
The dominant research topic is Sirtuins and Resveratrol in Medicine, which contains 120 papers. Other research areas include Phytochemicals and Antioxidant Activities, Mitochondrial Function and Pathology, Autophagy in Disease and Therapy, and Cancer, Hypoxia, and Metabolism.
Who are the most prolific authors publishing on resveratrol?
Dipak K. Das from the University of Connecticut leads with 48 papers on resveratrol. Other highly productive authors include Beata Olas from the University of Łódź and Dominique Delmas from Université de Bourgogne, each with 28 papers.
What is the patent coverage across therapeutic and food application areas?
The largest patent category is A61K (pharmaceutical preparations), with 37,916 patents. A61P (pharmaceutical activity classification) contains 27,768 patents, while A23L and A23V together account for 15,108 patents related to food and nutrition applications. Notably, 11,710 patents were filed in the last three years.